High-grade glioma, pediatric

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Section editor
Nwood.jpeg
Nicole M. Wood, DO
University of Missouri
Kansas City, MO, USA

LinkedIn

This page contains studies that are specific to pediatric populations.

  • For the more general high-grade glioma category page, follow this link.
  • For pediatric low-grade glioma (pLGG), follow this link.
4 regimens on this page
5 variants on this page


Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

NCCN

Adjuvant therapy

Lomustine, Vincristine, Prednisone

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Finlay et al. 1995 (CCG-945) 1985-1990 Phase 3 (C) 8-drug regimen Did not meet primary endpoint of OS

Note: the exact schedule of vincristine is impossible to discern from Figure 1.

Preceding treatment

Chemotherapy

Glucocorticoid therapy

42-day cycle for 8 cycles

References

  1. CCG-945: Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC, Packer RJ; Children's Cancer Group. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol. 1995 Jan;13(1):112-23. link to original article contains dosing details in manuscript PubMed

Temozolomide & RT

Temozolomide & RT: Temozolomide & Radiation Therapy

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Grill et al. 2018 (HERBY) 2011-2015 Randomized Phase 2 (C) Temozolomide, Bevacizumab, RT Did not meet primary endpoint of EFS

Chemotherapy

  • Temozolomide (Temodar) as follows:
    • Cycle 1 (chemoradiation): 75 mg/m2 PO or IV once per day
    • Cycles 2 to 13: 150 to 200 mg/m2 PO once per day on days 1 to 5

Radiotherapy

  • Concurrent radiation therapy as follows:
    • Cycle 1: 180 cGy fractions x 30 fractions, for a total dose of 5400 cGy

6-week course, then 4-week break, then 28-day cycle for up to 12 cycles

References

  1. HERBY: Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, CaƱete A, Saran F, Le Deley MC, Varlet P, Morgan PS, Jaspan T, Jones C, Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L, Hargrave D, Vassal G. Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma. J Clin Oncol. 2018 Apr 1;36(10):951-958. Epub 2018 Feb 7. link to original article contains dosing details in manuscript PubMed NCT01390948

Vincristine & RT

Vincristine & RT: Vincristine & Radiation Therapy

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Finlay et al. 1995 (CCG-945) 1985-1990 Phase 3 (C) 8-drug regimen Did not meet primary endpoint of OS

Preceding treatment

Chemotherapy

Radiotherapy

70-day course

Subsequent treatment

References

  1. CCG-945: Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC, Packer RJ; Children's Cancer Group. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol. 1995 Jan;13(1):112-23. link to original article contains dosing details in manuscript PubMed

Recurrent disease, non-curative therapy, non-randomized or retrospective data

Temozolomide monotherapy

Regimen variant #1, no radiation history

Study Dates of enrollment Evidence
Nicholson et al. 2007 1998-1999 Non-randomized

Chemotherapy

  • Temozolomide (Temodar) 150 to 200 mg/m2 PO once per day on days 1 to 5
    • Patients who previously received craniospinal irradiation (CSI) instead received 180 mg/m2 PO once per day on days 1 to 5

28-day cycle for up to 11 cycles


Regimen variant #2, previous craniospinal irradiation (CSI)

Study Dates of enrollment Evidence
Nicholson et al. 2007 1998-1999 Non-randomized

Chemotherapy

28-day cycle for up to 11 cycles

References

  1. Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH; Children's Oncology Group. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Cancer. 2007 Oct 1;110(7):1542-50. link to original article contains dosing details in manuscript PubMed